From Texas Health and Human Services Commission <[email protected]>
Subject HHSC Removed Monovalent Moderna and Pfizer-BioNTech COVID-19 Vaccines From Formulary
Date May 4, 2023 2:03 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Texas Health and Human Services [ [link removed] ]

Blue Gradient


HHSC Removed Monovalent Moderna and Pfizer-BioNTech COVID-19 Vaccines From Formulary

HHSC removed the monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines from the formulary on April 21, 2023. A list of the affected vaccines [ [link removed] ] is available online.

Other news:


* HHSC to Update Hereditary Angioedema Clinical Prior Authorization For Fee-For-Service on May 23 [ [link removed] ]
* HHSC To Update Opioid Product Information in Clinical Prior Authorizations for Medicaid Fee-for-Service on June 22 [ [link removed] ]
* HHSC to Update Anxiolytics and Sedative-Hypnotics Clinical Prior Authorization For Fee-For-Service on June 22 [ [link removed] ]








________________________________________________________________________

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website [ [link removed] ].

________________________________________________________________________

Stay Connected Visit us on Facebook [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on Twitter [ [link removed] ] Visit us on Instagram [ [link removed] ] Visit us on Facebook [ [link removed] ]  (en español)  

Bookmark and Share [ [link removed] ]

Subscriber Services
Manage Preferences [ [link removed] ]  |  Unsubscribe [ [link removed] ]  |  Help [ [link removed] ]

________________________________________________________________________

This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo [ [link removed] ]
Screenshot of the email generated on import

Message Analysis